Network News
Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector Paris, June 8, 2026. The European Commission has approved Sarclisa (isatuximab) subcutaneous (SC) in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all existing indications for Sarclisa intravenous (IV) formulation. Sarclisa is […]
read more
New Publication by HI-STEM: Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML
Waclawiczek A, Leppä AM, Renders S, Bergerweiss I, Stumpf K, Betz B, Gabrowski S, Huang FY, Lalioti ME, Hempel B, Sohn M, Kuusanmäki H, Thiel V, Unglaub JM, Shahswar R, Richter S, Janssen M, Karpova D, Donato E, Bonig H, Röllig C, Raffel S, Heuser M, Hundemer M, Kontro M, Eisfeld AK, Sauer T, Cabezas-Wallscheid […]
read more
From Research to Everyday Life: App Speeds Up Information Flow for Rare Metabolic Disorders
Congenital metabolic disorders such as phenylketonuria (PKU) have a profound impact on the daily lives of those affected: they must follow a strict diet and have their blood levels checked regularly. An app developed by a team from Heidelberg University’s Faculty of Medicine in collaboration with partners is designed to make daily life easier for […]
read more
Tracing environmental change through river microbiomes in Luxembourg
New TREC pilot project explores how microbial life along rivers reflects environmental change and supports ecosystem health The European Molecular Biology Laboratory (EMBL) and regional partners, including the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, have launched a pilot project in the Luxembourg area to investigate how microbial life within river […]
read more
Connecting tissue physical changes to what developing cells become
Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development Summary Embryonic development is one of the most dynamic biological processes in nature. Cells and tissues organise and reorganise themselves following incredibly precise patterns, while remaining flexible and robust. Scientists […]
read more
Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR
Data highlight a mechanistic link between ribosomal stress pathways and biomarker generation, with potential implications for patient stratification and treatment response HEIDELBERG, Germany, June 2, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company focused on blood-based tests for early disease detection and precision medicine, today announced that it will present new findings supporting the […]
read more
Why pain persists long after injuries have healed
Prof. Dr. Rohini Kuner of the Heidelberg Faculty of Medicine at Heidelberg University awarded the 2026 Jung Prize for Medicine Chronic pain is among the most common and burdensome health conditions worldwide. But which processes in the nervous system cause pain to be “learned” and thus persist long term? And how can insights into the […]
read more
New HI-STEM Publication: A kinetics-based model of haematopoiesisreveals extrinsic regulation of skewed lineageoutput from stem cells
Rodríguez-Correa, E., Grünschläger, F., Nizharadze, T. et al. A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells. Nat Cell Biol (2026). https://doi.org/10.1038/s41556-026-01958-0 https://www.nature.com/articles/s41556-026-01958-0 Abstract Haematopoietic stem cells (HSCs) display extensive molecular and functional heterogeneity. However, a cohesive model that explains the relationship and biological relevance of these diverse HSC states remains elusive. Here, […]
read more
Heidelberg-based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)
Joint press release of the Heidelberg Faculty of Medicine at Heidelberg University and the German Center for Infection Research: With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the German Center for Infection Research (DZIF) has now […]
read more
